Many biomarkers identified in marker discovery are shown to have inadequate performance in validation studies. This motivates the use of group sequential designs that allow early termination for futility. However, an option for early termination will lead to biased estimates for studies that reach full enrollment. We propose conditional estimators and confidence intervals that correct for this bias assuming that an unadjusted estimator exists that has an independent increments covariance structure.
Introduction
Biomarkers are identified during marker discovery and their performance is evaluated in subsequent validation studies. The majority of candidate markers will not have adequate performance upon further evaluation.
This, along with the need to conserve specimens and minimize cost, motivates the use of group sequential study designs that allow early termination for poorly performing markers.
Group sequential designs that allow early termination for futility lead to biased estimates of marker performance in studies that reach full enrollment. A candidate marker will have to show signs of promise at interim analyses in order to reach full enrollment, leading to optimistic estimates at study completion. Biased estimates at study completion have negative consequences even when the markers are studied further. These include: future studies wasted on inadequate markers and future studies that are underpowered. In contrast, biased estimates from studies that appropriately terminate early are not of great concern because the marker is deemed inadequate and estimation of its performance is not of interest. Due to these differences in the scientific implications we believe it is inappropriate to average over stopping times when studying the statistical properties of estimators used after group sequential studies that allow early termination for futility. Instead, we focus on properties conditional on reaching full enrollment.
Group sequential designs for diagnostic biomarker studies have been discussed in the literature (Mazumdar, 2004; Mazumdar and Liu, 2003; Tang et al., 2008) . These methods are most appropriate in settings where markers already exist and the focus is on comparisons between markers and controlling the type-I error rate. However, our primary concern is estimation of the performance characteristic of a new biomarker or biomarker combination. Estimation after group sequential studies has been studied in the therapeutic clinical trials literature (Emerson and Fleming, 1990) . These methods were developed to maintain good statistical properties averaging over all possible stopping times whereas our interest lies in estimators with good statistical properties conditional on reaching full enrollment. Pepe et al. (2009) considered conditional estimation of sensitivity and specificity for a dichotomous diagnostic 1 biomarker. They proposed the conditional UMVUE for a binomial probability after a two-stage study that allows early termination for futility. The conditional UMVUE performed well in simulation studies but its use is limited to evaluation of the performance of a dichotomous marker. In practice, many biomarkers are continuous. There is a need to extend these methods to accommodate the evaluation of continuous markers.
In Section 2, we discuss conditional estimation of a normal mean after a two-stage study that allows early termination for futility. In Section 3, we discuss how the results from Section 2 can be generalized to conditional estimation of any parameter when an unadjusted estimator exists that is asymptotically normal with an independent increments covariance structure. In Sections 4 and 5, we apply these results to conditional estimation of the receiver operating characteristic (ROC) curve and the positive predictive value (PPV) curve, two common summaries of performance for a continuous biomarker. Finally, we summarize our work and suggest possible extensions in Section 6.
A General Framework for Conditional Estimation

Notation and Study Design
Consider a two-stage study that allows early termination for futility. Let x 1 , . . . , x n be i.i.d. normal random variables with mean, β, and known variance, σ 2 , where the first n stg1 observations are drawn in stage one and the remaining n − n stg1 observations are drawn in stage 2. Furthermore, letβ stg1 be the sample mean for the first n stg1 observations,β all be the sample sample mean for all n observations and define, all are the variances ofβ stg1 andβ all , respectively. β stg1 ,β all follows a bivariate normal distribution with an independent increments covariance structure. That is,
have independent increments. In the diagnostic testing setting, we will often consider estimators that follow this distribution approximately. We discuss conditional estimation when β stg1 ,β all are asymptotically normal in Section 3.
Our focus is on estimation after study completion and, rather than discussing the specifics of study design, we only assume that the study has continuation regions of the form
where C is an indicator function taking the value 1 if the study continues to stage 2 and 0 if the study terminates after stage 1. We note that this implies thatβ all is undefined, or at the very least, unobserved, when C = 0. This is a sufficiently broad class of stopping rules that should include any sensible two-stage design that allows early termination for futility.
Behavior of the Unadjusted Estimate Conditional on Study Completion
We begin by investigating the behavior ofβ all for studies that reach full enrollment.β stg1 andβ all follow a bivariate normal distribution in studies that do not allow early termination. In contrast,β stg1 follows a truncated normal distribution conditional on reaching full enrollment in a study that allows for early termination. Therefore, the joint density ofβ stg1 andβ all conditional on reaching full enrollment is
where f (β stg1 ,β all |β) is the bivariate normal density and I is an indicator function that takes the value 0 if β stg1 is less than h and 1 ifβ stg1 is greater than h. Integrating (1) with respect toβ stg1 gives the conditional
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The conditional density is essentially the marginal normal density multiplied by a term that changes the shape of the distribution depending on the probability of early termination. There will be large deviations from the normal density for lower values of β due to the high probability of early termination but very little deviation from the normal density for higher values of β when it is unlikely that the study terminates after stage 1.
We next consider the effect of early termination on the conditional mean and variance ofβ all . The mean of β all conditional on reaching full enrollment is
To see this, note that Cov β stg1 /σ
Solving the previous equation for E β all |C = 1 , we obtain
Taking the expectation of E β stg1 − β /σ stg1 |C = 1 gives the desired result. From (3), we see that bias increases as the cut-off for continuing to full enrollment, h, and the ratio of the variance ofβ all to the standard deviation ofβ stg1 increase. In contrast, the bias decreases as the true value of β increases. The
The conditional variance ofβ all will be used in the next section when we present bias adjusted conditional estimators. A detailed deriviation of the conditional variance and an example illustrating the effect of early termination on the density and conditional expectation can be found in Appendix A.
Bias Corrected Conditional Estimation
In this section, we consider three biased corrected estimators and examine some of their properties. The first is motivated by Whitehead (1986) who derived the bias of the MLE after a sequential trial and proposed a mean adjusted estimator to correct for this bias. We define a conditional mean adjusted estimator,β mn , as the solution to the following equationβ
The mean adjusted estimator is the value of β that results in a conditional mean equal toβ all . This estimator is equivalent to the K-th order bias adjusted estimator proposed by Troendle and Yu (1999) and the conditional maximum likelihood estimator discussed by Liu et al. (2004) .
Theorem 2.1.β mn is approximately conditionally unbiased with variance
Proof Using a Taylor expansion,β mn can be approximated bŷ
Taking the expectation and variance of the right side of (6) gives the result.
The second estimator is motivated by Whitehead's median adjusted estimator (Whitehead, 1983 ) that solves for the value of β that results in a marginal median equal to the observed value ofβ all . Again, we extend this to the conditional case by using the conditional density. The conditional median adjusted estimator, β md , is the solution to the following equation
where f ( ·| β, C = 1) is the conditional density from (2) and F ( ·| β, C = 1) is the conditional CDF.β md is the value of β that results in a conditional median equal toβ all . Similar median adjusted estimators for conditional estimation after adaptive clinical trials have been discussed in the literature (James Hung et al., 2006; Wang et al., 2010) .
Theorem 2.2.β md is approximately conditionally median unbiased and has conditional mean and variance equal to
Proof Using a Taylor expansion,β md can be approximated by
From (8) we can show thatβ md is approximately median unbiased
The mean and variance ofβ md can be found by applying the delta method to the right side of (8).
The third estimator is motivated by the conditional UMVUE for a binomial probability after a two-stage study that allows early termination for futility (Pepe et al., 2009 ). The conditional UMVUE for a binomial probability is the expectation of the sample proportion using only stage 2 data conditional on the sample proportion using all data and the study reaching full enrollment. We can follow the same approach to define the conditional UMVUE for a normal mean after a two-stage study that allows early termination for futility, which we call the Rao-Blackwell estimator,β rb ,
whereβ stg2 is the sample mean using only stage 2 data.
Theorem 2.3.β rb is the conditional UMVUE and has variance,
Proof Conditional on C = 1, the density of the X i 's is a single parameter exponential family with complete sufficient statisticβ all (Casella and Berger, 2002) .β rb is the conditional UMVUE by the Rao-Blackwell
Theorem. The conditional variance ofβ rb is an application of the delta method.
Theorem 2.3 illustrates the advantage to considering the special case of estimation conditional on full enrollment in a two-stage study that allows early termination for futility. Estimators that consider conditional estimation more generally only provide approximate unbiasedness, whereas we are able to derive an estimator that is not only unbiased but optimal within the class of unbiased estimators.
Whileβ rb is optimal for conditional estimation of a normal mean, this will not necessarily be the case whenβ is asymptotically normal. For this reason,β mn andβ md are still of interest and their performance will be compared to the performance ofβ rb when we consider conditional estimation of the ROC and PPV curves in Sections 4 and 5.
Small-sample Properties
The theoretical results presented in Section 2.3 show thatβ rb is optimal within the class of unbiased estimators but do not provide information about its relative merits compared to approximately unbiased estimatorŝ β mn andβ md . We completed a small simulation study to compare the performance ofβ rb ,β mn andβ md .
Data were simulated from i.i.d normal distributions with mean β and known variance equal to 1. We considered sample sizes of 20, 40 and 60, with one interim analysis using 10, 20 and 30 observations, respectively.
The study terminates for futility if the upper limit of the 95% confidence interval formed at the interim analysis is less than 0.8. All summaries are based only on studies that reached full enrollment. 10,000
simulations were considered for each scenario. Table 1 presents simulation results comparing the performance ofβ rb ,β mn andβ md . Also included are summaries for the biased, naive estimator that considers all of the data and does not adjust for the possibility of early termination,β all , and the estimator only using the stage 2 data,β stg2 , which represents the simplest conditionally unbiased estimator but is inefficient. We see thatβ rb is unbiased and has smaller standard error thanβ stg2 but larger standard error thanβ all .β md andβ md have similar standard errors tô β rb (smaller, in some cases) but are biased, over-correcting for the bias inβ all . The bias decreases as sample size increases but a small amount of bias is still visible when n = 60. Finally, standard errors ofβ rb ,β mn andβ md are larger than the standard error forβ all when β is small and there is a high probability for early termination but there is little difference when β is larger and early termination is rare.
Conditional Confidence Intervals
Unadjusted confidence intervals forβ all fail to provide correct coverage conditional on reaching full enrollment. The conditional coverage probability can be found by integrating (2) and ranges from 0 to the nominal rate depending on the probability of early termination. An example illustrating the effect of early termination on unadjusted confidence intervals is in Appendix A. Standard approaches to forming confidence intervals after group sequential clinical trials (Emerson and Fleming, 1990; Jennison and Turnbull, 1989; Tsiatis et al., 1984 ) also fail to provide uniformly correct conditional coverage (Ohman-Strickland and Casella, 2003) . This is not surprising as these confidence intervals were developed to provide correct coverage averaging over all stopping times. Different approaches are needed to provide correct coverage conditional on reaching full enrollment.
Ohman-Strickland and Casella (2003) present conditional confidence intervals for a normal mean that provide adequate conditional coverage. Following their approach, we define (β L , β U ) as a 1 − α conditional confidence interval where
and α 2 = F (β all |β U , C = 1). Table 1 : Simulation results illustrating the small-sample properties of the estimators presented in Section 2 using a sample size of n and an interim analysis using the first n stg1 observations. The study terminates if the upper limit of the 95% confidence interval formed at the interim analysis is less than 0.8. Shown are the mean(se) of estimated β for studies that reached full enrollment. 10000 simulated studies per scenario. These intervals provide correct conditional coverage, as we are simply pivoting the conditional CDF (Casella and Berger, 2002) , and are the uniformly most accurate 1 − α level conditional confidence interval for β (Ohman-Strickland and Casella, 2003) .
Conditional Estimation whenβ is Asymptotically Normal
In the diagnostic testing setting, we often work with estimators that are asymptotically normal with an independent increments covariance structure. For example, a binomial proportion, such as the true positive fraction (TPF) or the false positive fraction (FPF), when estimated using the sample proportion or the empirical estimate of a point on the receiver operating characteristic (ROC) curve are asymptotically normal with an independent increments covariance structure (Koopmeiners, 2009) . Furthermore, we must also account for the possibility that the variance ofβ depends on the true value of β. The estimators and confidence intervals propossed in Section 2 can be adapted to these settings.
Letβ be an estimate of marker performance, β. Recall thatβ stg1 is the estimate of β using only data from stage 1 andβ all is the estimate of β at full enrollment. Assume that β stg1 ,β all is asymptotically normal with,   β increments. This is a common distributional assumption in the group-sequential testing literature (Jennison and Turnbull, 2000) . We use the notation, σ 2 β,stg1 and σ 2 β,all , to indicate that the variance ofβ is allowed to depend on β, which will often be the case in the diagnostic testing setting.
To calculate the mean adjusted estimator whenβ is asymptotically normal, we let b (β|C = 1) depend on β through σ 2 β,stg1 and σ 2 β,all and solve (5) numerically. Similarly, the median adjusted estimator is calculated by allowing f (x|β, C = 1) to depend on β through σ 2 β,stg1 and σ 2 β,all and solve (7) numerically. We have 11 applied these estimators with various mean-variance relationships, including the two found in Sections 4
and 5, and had no difficulty solving these equations using the nlm function in R. Whenβ is asymptotically normal with β-dependent variance, the Rao-Blackwell estimator becomes,
and must be calculated using an iterative procedure. At the first iteration,
−σ 2 β all ,all , and at subsequent iterations,
We continue until the difference betweenβ
is small. Calculation of the conditional confidence intervals whenβ is asymptotically normal is analagous to calculation of the median adjusted estimator.
It is often the case that σ 2 β,stg1 and σ 2 β,all depend on unknown nuisance parameters that must be estimated. For our examples in Sections 4 and 5, unadjusted estimates of the nuisance parameters using all data available at the end of stage 2 were plugged into the variance formulas and we proceeded to calculate the conditional estimators and confidence intervals as if the nuisance parameters were known.
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Conditional Estimation of ROC(t)
In this section, we apply our methods to conditional estimation of ROC(t), a point on the ROC curve. Let 
The ROC curve can alternately be expressed as
where S D (x) is the biomarker survival function for the cases, SD(x) is the biomarker survival function for the controls and t is the false positive fraction. ROC(t) is the true positive fraction corresponding to a false positive fraction equal to t.
The ROC curve is often estimated empirically in order to avoid making distributional assumptions about 
where r D and rD are the proportion of cases and controls, respectively, observed at the interium analysis.
The sequential empirical estimate of ROC(t) is asymptotically normal with an independent increments covariance structure (Koopmeiners, 2009 ) and variance
where n D and nD are the number of cases and controls, respectively, at full enrollment. Therefore, if we let 
and fD S −1 D (t) using a normal kernel density estimator and proceeded as if they were known.
Although we expect the normality approximation forROC r D ,rD (t) to work well, transformed values might provide faster convergence to normality. For example, the logit transformation is preferable when t or ROC(t) are close to 0 or 1 (Pepe, 2003) . We note that the conditional estimators and confidence intervals presented in Section 3 apply to transformed values as well.
Small Sample Properties
We simulated 10,000 studies of 400 cases and 400 controls with an interim analysis using data from 200 cases and 200 controls. We note that, while not what would typically considered a small sample size, 400 cases and 400 controls is representative of phase 2 diagnostic biomarker studies found in the literature (Marrero et al., 2009 ). Studies were terminated if the upper limit of the two-sided 95% Wald confidence interval for ROC(0.2) was less than 0.7. Marker values for the controls were simulated from a standard normal distribution while marker values for the cases were simulated from a normal distribution with variance 1 and mean chosen to achieve the desired true value of ROC(0.2). We are interested in the properties of our estimators and confidence intervals conditional on reaching full enrollment. Therefore, all summaries are based on only those studies that completed stage 2. If, for example, 75% of the studies terminated after stage 1, then summaries are based on the 2,500 studies that completed stage 2. Table 2 presents results for the unadjusted estimator and the three bias-adjusted estimators. Summaries for ROC(0.2) stg2 , the empirical estimator using only stage 2 data, are also included because it is the simplest estimator that is not biased by the possibility of early termination. However, ROC(0.2) stg2 is inefficient because it does not use all of the observations. The bias of the unadjusted estimator is substantial and decreases as ROC(0.2) increases. All three bias corrected estimators provide unbiased estimates of ROC (0.2) and have smaller standard errors than ROC(0.2) stage2 . They have larger standard errors than ROC(0.2) all but the difference decreases as ROC (0.2) increases and the difference is negligiblel when ROC(0.2) > 0.7. Table 3 presents coverage probabilities and average widths. The unadjusted Wald interval provides correct conditional coverage when ROC(0.2) > 0.6 but not when there is a high probability of early termination.
The conditional intervals provide coverage that is slightly below the nominal level (approximately 0.94) but provide substantially better conditional coverage than the unadjusted intervals when ROC(0.2) < 0.6 and the study is likely to terminate early. The conditional confidence intervals are wider than the unadjusted intervals but the difference decreases as ROC(0.2) increases. For example, the conditional intervals are 27%
wider when ROC(0.2) = 0.55 but are nearly the same width when ROC(0.2) > 0.7. 
Conditional Estimation of PPV(u)
The predictive accuracy of a binary marker can be evaluated by the positive predictive value (PPV) and negative predictive value (NPV). The PPV and NPV curves have been proposed as a method for evaluating the predictive accuracy of a continuous marker (Moskowitz and Pepe, 2004; Zheng et al., 2008) . Let D be the binary outcome, ρ = P rob(D = 1) and let X denote the biomarker value with conditional distribution 
That is, the PPV and NPV curves are defined as P P V (u) = P D = 1|X > F −1 (u) and
for all u ∈ (0, 1). We can also write
where
is the marginal distribution function for X in the entire population.
Consider conditional estimation of P P V (u) under case-control sampling. Estimation for N P V (u) is analagous.
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The sequential empirical estimator of P P V (u) under case-control sampling is defined by plugging the sequential empirical estimates of S D (x) and F −1 (u) into (11)
where r D and rD refer to the proportion of cases and controls, respectively, observed at a given time point and ρ is assumed known. The sequential empirical estimator of P P V (u) is asymptotically normal with an independent increments covariance structure (Koopmeiners, 2009 ) and variance
where n D and nD are the number of cases and controls, respectively, at full enrollment. Therefore, if we let
can use the estimators proposed in Section 3 to estimate P P V (u) after a two-stage study that allows early termination for futility. The variance of P P V r D ,rD (u) depends on fD F −1 (u) and f F −1 (u) , which must be estimated in order to use the estimators from Section 3. Again, we estimated fD F −1 (u) and f F −1 (u) using a normal kernel density estimator and proceeded as if they were known.
Small Sample Properties
We simulated 10,000 studies with 200 cases and 200 controls allowing early termination after 100 cases and 100 controls. The parameter of interest was P P V (0.9), the positive predictive value when biomarker values at the 90th percentile or above are considered positive. Early termination occured if the upper limit of the two-sided 95% Wald confidence interval for P P V (0.9) was less than 0.8. Marker values for the controls were simulated from a standard normal distribution while marker values for the cases were simulated from a normal distribution with variance 1 and mean chosen to achieve the desired true value of P P V (0.9). Again, Table 4 : Simulation results for conditional estimation of P P V (u) using 200 cases and 200 controls, an interim analysis using the first 100 cases and 100 controls where the study terminates if the upper limit of the 95% confidence interval formed at the interim analysis is less than 0.8. Shown are the mean(se) of estimated P P V (0.9) for studies that reached full enrollment. 10000 simulated studies per scenario.
True % Early PPV(0.9) Stopping P P V (0.9) all P P V (0.9)stg2 P P V (0.9) md P P V (0.9)mn P P V (0. all summaries are based on only those studies that reached full enrollment. Table 4 presents simulation results evaluating the bias and standard errors of the three bias adjusted estimators along with the unadjusted empirical estimator, P P V (0.9) all , and the empirical estimator using only stage 2 data, P P V (0.9) stg2 . The unadjusted estimator has substantial bias that decreases as P P V (0.9) increases. The three bias adjusted estimators are unbiased and have standard errors that are larger than P P V (0.9) all but smaller than P P V (0.9) stg2 . We see that the difference between the standard errors of P P V (0.9) all and the three bias adjusted estimators decreases as P P V (0.9) increases. Table 5 presents conditional coverage probabilities and average widths for the unadjusted 95% Wald confidence interval and the conditional confidence interval. We see that the unadjusted interval provides correct conditional coverage when P P V (0.9) ≥ 0.65 but not for smaller values of P P V (0.9). Again, we see that the coverage probability for the conditional intervals are below the nominal rate (between 0.92 and 0.93 in most cases) but the conditional intervals provide a clear improvement over the unadjusted intervals when P P V (0.9) < 0.65 and the Table 5 : Simulation results for conditional estimation of P P V (u) using 200 cases and 200 controls, an interim analysis using the first 100 cases and 100 controls where the study terminates if the upper limit of the 95% confidence interval formed at the interim analysis is less than 0.8. Shown are the conditional coverage probabilities for studies that reached full enrollment. 10000 simulated studies per scenario. study is likely to terminate early. The conditional intervals are wider than the unadjusted intervals but we see that the difference decreases as P P V (0.9) increases.
Discussion
We present a general framework for conditional estimation after a two-stage study that allows early termination for futility. We show that the unadjusted estimator has substantial bias conditional on reaching full enrollment and propose three bias adjusted conditional estimators. The three bias adjusted estimators are shown to have good theoretical properties conditional on reaching full enrollment and perform well in two small simulation studies. All three estimators correct for the bias due to early termination with a minimal loss in efficiency when there is only a small chance of early termination.
Neither unadjusted confidence intervals, that do not account for the possibility of early termination, nor standard approaches to forming confidence intervals after group sequential studies provide adequate conditional coverage. Confidence intervals that provide correct conditional coverage for a normal mean have been discussed in the literature (Ohman-Strickland and Casella, 2003) . In Sections 4 and 5, we apply these intervals to the case whereβ is asymptotically normal. The conditional intervals are wider than the unadjusted intervals but the difference is small for large values of the performance parameter of interest.
There are limitations to conditional estimation. Conditional estimation results in a loss of information compared to the unconditional approach and, for this reason, it is important to consider the scientific implications when deciding between the two. In the diagnostic testing setting, where high-quality resources are very scarce, we feel that the scientific implications (i.e. future studies of inadequate markers or underpowered future studies) support the use of conditional estimation.
We have proposed an estimator that is unbiased conditional on reaching full enrollment but we did not discuss conditional estimation for studies that terminated early for futility. Estimators that adjust for bias conditional on early termination exist but are not unbiased (Liu et al., 2004; Troendle and Yu, 1999) . Therefore, we are left to choose between an approach that is biased conditional on early termination, biased conditional on reaching full enrollment but unbiased unconditionally and an approach that is biased conditional on early termination, unbiased conditional on reaching full enrollment and biased unconditionally.
The former is the standard approach in the clinical trials literature but, again, we feel that the scientific implications make the second approach more appropriate in the diagnostic testing setting.
Our simulation results illustrate that the conditional estimators and confidence intervals proposed in this paper can be applied whenβ is only asymptotically normal. This is a standard assumption in the group sequential testing literature. We chose to focus on conditional estimation of ROC(t) and P P V (u) where the independent increments structure holds and we expect the assumption to hold for other measures of discrimination such as AUC.
We framed our discussion in the context of a diagnostic biomarker study. However, the same methods can be used in a therapeutic study as well as long as conditional estimation is appropriate and an unadjusted estimator of treatment effect exists that meets the independent increments assumption.
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The Early Detection Research Network has several biomarker validation studies underway that utilize twostage designs that allow early termination for futility. This paper provides methodology for conditional estimation at study completion but further research is needed to identify strategies for designing diagnostic biomarker studies that utilize conditional estimation at study termination. The sample size used in stage 1, overall sample size and criteria for early termination should be determined in order to achieve desired type-I error rate and power while minimizing expected sample size.
We considered the case of a two-stage design that evaluates the performance of a single biomarker. Another possibility is group sequential designs that evaluate the performance of several markers at once. In this case, the stopping rule may be applied to one marker but unbiased estimates are desired for the other markers as well. Conditional estimation of a secondary parameter after a group sequential trial has been discussed in the literature (Liu et al., 2004) . This may provide a starting point for developing conditional estimators for several markers when a group sequential stopping rule is applied to only one marker.
truncated normal distribution conditional on C = 1. 
A.2 Illustration of the effect of early termination onβ all
To illustrate the effect of early stopping we consider estimation of ROC(t) after a two-stage study that allows early termination for futility. ROC(t) is the sensitivity at a specificity of 1 − t. In this example, we consider ROC(0.2), the sensitivity at a specificity of 0.8. The empirical estimate of ROC(0.2) is asymptotically normal and has an independent increments covariance structure (Koopmeiners, 2009) . Consider a two stage study with 400 cases and 400 controls, an interim analysis using the first 200 cases and 200 controls, where the study terminates if the upper limit of the 95% confidence interval formed at the interim analysis is less than 0.7. Figure 1 presents the conditional asymptotic density of the empirical estimate of ROC(0.2) for different true values of ROC(0.2). The solid line represents the conditional asymptotic density, while the dashed line represents the usual unconditional asymptotic normal density for the empirical estimate of ROC(0.2). There is considerable difference between the conditional and unconditional density when ROC(0.2) is equal to 0.55 but very little difference when ROC(0.2) equals 0.65 and the probability of early termination is low. Figure 2 presents the conditional mean of ROC(0.2) all under different design scenarios. We consider a twostage study designs with 400 cases and 400 controls, one interim analysis using the first 30%, 40% or 50% of .2) increases. In contrast, the bias increases as the cut-off for continuing to full enrollment and the number of subjects used in stage 1 increase as they both increase the probability of early termination.
Finally, we illustrate the effect of early termination on the coverage probability of an unadjusted confidence interval. Consider the usual Wald confidence interval for ROC(t), R OC(t) all − Z a/2 * σR OC(t) all ,ROC(t) all + Z a/2 * σR OC(t) all .
We can calculate the conditional coverage of the Wald confidence interval using the conditional density from Section 2. .2) all in a two-stage study with 400 cases and 400 controls. An interim analysis was completed using 30%, 40% or 50% of the subjects and continued to full enrollment if the 95% confidence interval for ROC(0.2) formed at the interim analysis was less than 0.70 or 0.80.
